Lone atrial fibrillation: Does it exist?

Journal of the American College of Cardiology

Volumn 63, Issue 17, 2014, Pages 1715-1723

  Wyse, D George ^a   Van Gelder, Isabelle C ^b   Ellinor, Patrick T ^c   Go, Alan S ^d   Kalman, Jonathan M ^e   Narayan, Sanjiv M ^f   Nattel, Stanley ^g   Schotten, Ulrich ^h   Rienstra, Michiel ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d DIVISION OF RESEARCH   (United States)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g MONTREAL HEART INSTITUTE   (Canada)

^h MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

idiopathic atrial fibrillation; lone atrial fibrillation; white paper

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; FIBROBLAST; GENETIC ASSOCIATION; HEART ATRIUM FIBRILLATION; HUMAN; LONE ATRIAL FIBRILLATION; MEDICAL RESEARCH; NOMENCLATURE; NONHUMAN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SINUS RHYTHM; TRANSTHORACIC ECHOCARDIOGRAPHY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; COMORBIDITY; DIAGNOSTIC PROCEDURE; ELECTROCARDIOGRAM; EXERCISE TEST; GENETIC PREDISPOSITION; HEART ATRIUM ENLARGEMENT; IDIOPATHIC DISEASE; MEDICAL TERMINOLOGY; PROGNOSIS; REVIEW; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

IDIOPATHIC ATRIAL FIBRILLATION; LONE ATRIAL FIBRILLATION; WHITE PAPER;

AGE FACTORS; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; DISEASE PROGRESSION; HEART CONDUCTION SYSTEM; HEART DISEASES; HUMANS; INCIDENCE; RISK FACTORS; WORLD HEALTH;

EID: 84899654397     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.01.023     Document Type: Review

References (104)

1. Geisel T (Dr. Seuss). Horton Hatches the Egg. 1940. Available at: http://en.wikipedia.org/wiki/Horton-Hatches-the-Egg. Accessed February 19, 2014.
2. Y. Miyasaka, M.E. Barnes, and B.J. Gersh et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 2006 119 125
3. Y. Miyasaka, M. Barnes, and R. Petersen et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort Eur Heart J 28 2007 1962 1967
4. B.P. Krijthe, A. Kunst, and E.J. Benjamin et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060 Eur Heart J 34 2013 2746 2751
5. S.S. Chugh, R. Havmoeller, and K. Narayanan et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study Circulation 129 2014 837 847
6. B.A. Schoonderwoerd, M.D. Smit, L. Pen, and I.C. Van Gelder New risk factors for atrial fibrillation: causes of "not-so-lone atrial fibrillation" Europace 10 2008 668 673
7. P. Kirchhof, G.Y. Lip, and I.C. Van Gelder et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options - a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference Europace 14 2012 8 27
8. W. Evans, and P. Swann Lone auricular fibrillation Br Heart J 16 1954 189 194
9. S. Levy Epidemiology and classification of atrial fibrillation J Cardiovasc Electrophysiol 9 suppl 1998 78 82
10. R. Wakili, N. Voigt, S. Kaab, D. Dobrev, and S. Nattel Recent advances in the molecular pathophysiology of atrial fibrillation J Clin Invest 121 2011 2955 2968
11. V. Fuster, L.E. Ryden, and D.S. Cannom et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 57 2011 e101 e198
12. A.J. Camm, P. Kirchhof, and G.Y. Lip et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC) Europace 12 2010 1360 1420
13. B. Weijs, C.B. de Vos, and R.G. Tieleman et al. The occurrence of cardiovascular disease during 5-year follow-up in patients with idiopathic atrial fibrillation Europace 15 2013 18 23
14. B. Weijs, R. Pisters, and R.J. Haest et al. Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls Heart Rhythm 9 2012 1923 1929
15. A. Jahangir, V. Lee, and P.A. Friedman et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation: a 30-year follow-up study Circulation 115 2007 3050 3056
16. X. Jouven, M. Desnos, C. Guerot, and P. Ducimetiere Idiopathic atrial fibrillation as a risk factor for mortality. The Paris Prospective Study I Eur Heart J 20 1999 896 899
17. S.L. Kopecky, B.J. Gersh, and M.D. McGoon et al. The natural history of lone atrial fibrillation. A population-based study over three decades N Engl J Med 317 1987 669 674
18. S.L. Kopecky, B.J. Gersh, and M.D. McGoon et al. Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk Arch Intern Med 159 1999 1118 1122
19. M. Nabauer, A. Gerth, and T. Limbourg et al. The registry of the German Competence Network on Atrial Fibrillation: patient characteristics and initial management Europace 11 2009 423 434
20. R. Nieuwlaat, A. Capucci, and A.J. Camm et al. Atrial fibrillation management: a prospective survey in ESC member countries. The Euro Heart Survey on Atrial Fibrillation Eur Heart J 26 2005 2422 2434
21. C.-E. Chiang, L. Naditch-Brule, and J. Murin et al. Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry Circ Arrhythm Electrophysiol 5 2012 632 639
22. B. Weijs, R. Pisters, and R. Nieuwlaat et al. Idiopathic atrial fibrillation revisited in a large longitudinal clinical cohort Europace 14 2012 184 190
23. J.B. Close, D.W. Evans, and S.M. Bailey Persistent lone atrial fibrillation - its prognosis after clinical diagnosis J R Coll Gen Pract 29 1979 547 549
24. S. Scardi, C. Mazzone, C. Pandullo, D. Goldstein, A. Poletti, and F. Humar Lone atrial fibrillation: prognostic differences between paroxysmal and chronic forms after 10 years of follow-up Am Heart J 137 1999 686 691
25. E. Davidson, Z. Rotenberg, I. Weinberger, J. Fuchs, and J. Agmon Diagnosis and characteristics of lone atrial fibrillation Chest 95 1989 1048 1050
26. T.S. Potpara, G.R. Stankovic, and B.D. Beleslin et al. A 12-year follow-up study of patients with newly diagnosed lone atrial fibrillation: implications of arrhythmia progression on prognosis. The Belgrade atrial fibrillation study Chest J 141 2012 339 347
27. C.E. Chiang, L. Naditch-Brule, and J. Murin et al. Distribution profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry Circ Arrhythm Electrophysiol 5 2012 632 639
28. D.G. Wyse Idiopathic atrial fibrillation: a rose by any other name? Europace 14 2012 151 152
29. M. Osranek, F. Bursi, and K.R. Bailey et al. Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up Eur Heart J 26 2005 2556 2561
30. W.P. Abhayaratna, J.B. Seward, and C.P. Appleton et al. Left atrial size: physiologic determinants and clinical applications J Am Coll Cardiol 47 2006 2357 2363
31. L.F. Tops, M.J. Schalij, and J.J. Bax Imaging and atrial fibrillation: the role of multimodality imaging in patient evaluation and management of atrial fibrillation Eur Heart J 31 2010 542 551
32. S.J. Lester, E.W. Ryan, N.B. Schiller, and E. Foster Best method in clinical practice and in research studies to determine left atrial size Am J Cardiol 84 1999 829 832
33. S.S. Kuppahally, N. Akoum, and N.S. Burgon et al. Left Atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI Circ Cardiovasc Imaging 3 2010 231 239
34. V. Mor-Avi, L. Sugeng, and R.M. Lang Real-time 3-dimensional echocardiography: an integral component of the routine echocardiographic examination in adult patients? Circulation 119 2009 314 329
35. R. Artang, R. Migrino, L. Harmann, M. Bowers, and T. Woods Left atrial volume measurement with automated border detection by 3-dimensional echocardiography: comparison with magnetic resonance imaging Cardiovasc Ultrasound 7 2009 1 8
36. M. Daccarett, C.J. McGann, N.W. Akoum, R.S. MacLeod, and N.F. Marrouche MRI of the left atrium: predicting clinical outcomes in patients with atrial fibrillation Expert Rev Cardiovasc Ther 9 2011 105 111
37. K. Higuchi, M. Akkaya, N. Akoum, and N.F. Marrouche Cardiac MRI assessment of atrial fibrosis in atrial fibrillation: implications for diagnosis and therapy Heart 100 2014 590 596
38. M.A. Rosenberg, J.S. Gottdiener, S.R. Heckbert, and K.J. Mukamal Echocardiographic diastolic parameters and risk of atrial fibrillation: the Cardiovascular Health Study Eur Heart J 33 2012 904 912
39. C. Cuspidi, M. Rescaldani, and C. Sala Prevalence of echocardiographic left-atrial enlargement in hypertension: a systematic review of recent clinical studies Am J Hypertens 26 2013 456 464
40. L.G. Olsson, K. Swedberg, and A. Ducharme et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart Failure - Assessment of Reduction in Mortality and Morbidity (CHARM) program J Am Coll Cardiol 47 2006 1997 2004
41. G.C. Linssen, M. Rienstra, and T. Jaarsma et al. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction Eur J Heart Fail 13 2011 1111 1120
42. B.A. Mulder, D.J. Van Veldhuisen, and H.J. Crijns et al. Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS Eur J Heart Fail 14 2012 1171 1178
43. B.A. Mulder, D.J. Van Veldhuisen, and H.J. Crijns et al. Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post-hoc analysis of the RACE II study Eur J Heart Fail 15 2013 1311 1318
44. C.S. Fox, H. Parise, and R.B. D'Agostino Sr. et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring JAMA 291 2004 2851 2855
45. S.A. Lubitz, X. Yin, and J.D. Fontes et al. Association between familial atrial fibrillation and risk of new-onset atrial fibrillation JAMA 304 2010 2263 2269
46. D.O. Arnar, S. Thorvaldsson, and T.A. Manolio et al. Familial aggregation of atrial fibrillation in Iceland Eur Heart J 27 2006 708 712
47. I.E. Christophersen, L.S. Ravn, and E. Budtz-Joergensen et al. Familial aggregation of atrial fibrillation: a study in Danish twins Circ Arrhythm Electrophysiol 2 2009 378 383
48. D.F. Gudbjartsson, D.O. Arnar, and A. Helgadottir et al. Variants conferring risk of atrial fibrillation on chromosome 4q25 Nature 448 2007 353 357
49. D.F. Gudbjartsson, H. Holm, and S. Gretarsdottir et al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke Nat Genet 41 2009 876 878
50. E.J. Benjamin, K.M. Rice, and D.E. Arking et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry Nat Genet 41 2009 879 881
51. P.T. Ellinor, K.L. Lunetta, and C.M. Albert et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation Nat Genet 44 2012 670 675
52. P.T. Ellinor, K.L. Lunetta, and N.L. Glazer et al. Common variants in KCNN3 are associated with lone atrial fibrillation Nat Genet 42 2010 240 244
53. M. Haissaguerre, P. Jais, and D.C. Shah et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins N Engl J Med 339 1998 659 666
54. M.A. Allessie, F.I. Bonke, and F.J. Schopman Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle Circ Res 41 1977 9 18
55. N.M. de Groot, R.P. Houben, and J.L. Smeets et al. Electropathological substrate of longstanding persistent atrial fibrillation in patients with structural heart disease: epicardial breakthrough Circulation 122 2010 1674 1682
56. S. Saksena, N.D. Skadsberg, H.B. Rao, and A. Filipecki Biatrial and three-dimensional mapping of spontaneous atrial arrhythmias in patients with refractory atrial fibrillation J Cardiovasc Electrophysiol 16 2005 494 504
57. C. Schmitt, G. Ndrepepa, and S. Weber et al. Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation Am J Cardiol 89 2002 1381 1387
58. C.S. Elayi, L. Di Biase, and C. Barrett et al. Atrial fibrillation termination as a procedural endpoint during ablation in long-standing persistent atrial fibrillation Heart Rhythm 7 2010 1216 1223
59. E. Patterson, R. Lazzara, and B. Szabo et al. Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins J Am Coll Cardiol 47 2006 1196 1206
60. B.J. Scherlag, H. Nakagawa, and W.M. Jackman et al. Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation J Interv Cardiac Electrophysiol 13 2005 37 42
61. S. Nattel Paroxysmal atrial fibrillation and pulmonary veins: relationships between clinical forms and automatic versus re-entrant mechanisms Can J Cardiol 29 2013 1147 1149
62. E.B. Saad, W.I. Saliba, N.F. Marrouche, and A. Natale Pulmonary vein firing triggering atrial fibrillation after open heart surgery J Cardiovasc Electrophysiol 13 2002 1300 1302
63. C.H. Calkins 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design Heart Rhythm 9 2012 632 696
64. L.-F. Hsu, P. Jais, and P. Sanders et al. Catheter ablation for atrial fibrillation in congestive heart failure N Engl J Med 351 2004 2373 2383
65. M.N. Khan, P. Jais, and J. Cummings et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure N Engl J Med 359 2008 1778 1785
66. S.M. Narayan, P. Clopton, D.E. Krummen, K. Shivkumar, and J. Miller Direct or coincidental ablation of localized sources may explain the success of atrial fibrillation ablation. On treatment analysis from the CONFIRM trial J Am Coll Cardiol 62 2013 138 147
67. M.C. Wijffels, C.J. Kirchhof, R. Dorland, and M.A. Allessie Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats Circulation 92 1995 1954 1968
68. M. Allessie The "second factor": a first step toward diagnosing the substrate of atrial fibrillation? J Am Coll Cardiol 53 2009 1192 1193
69. M.K. Stiles, B. John, and C.X. Wong et al. Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the "second factor" J Am Coll Cardiol 53 2009 1182 1191
70. C. Mahnkopf, T.J. Badger, and N.S. Burgon et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI: implications for disease progression and response to catheter ablation Heart Rhythm 7 2010 1475 1481
71. A.W. Teh, P.M. Kistler, and G. Lee et al. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease J Cardiovasc Electrophysiol 23 2012 232 238
72. G. Lalani, A. Schricker, M. Gibson, A. Rostamanian, D.E. Krummen, and S.M. Narayan Atrial conduction slows immediately before the onset of human atrial fibrillation: a bi-atrial contact mapping study of transitions to atrial fibrillation J Am Coll Cardiol 59 2012 595 606
73. S. Nattel New ideas about atrial fibrillation 50 years on Nature 415 2002 219 226
74. S.M. Narayan, D.E. Krummen, K. Shivkumar, P. Clopton, W.-J. Rappel, and J. Miller Treatment of atrial fibrillation by the ablation of localized sources. The Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation: CONFIRM trial J Am Coll Cardiol 60 2012 628 636
75. K. Shivkumar, K.A. Ellenbogen, J.D. Hummel, J.M. Miller, and J.S. Steinberg Acute termination of human atrial fibrillation by identification and catheter ablation of localized rotors and sources: first multicenter experience of focal impulse and rotor modulation (FIRM) ablation J Cardiovasc Electrophysiol 23 2012 1277 1285
76. K. Konings, C. Kirchhof, J. Smeets, H. Wellens, O. Penn, and M. Allessie High-density mapping of electrically induced atrial fibrillation in humans Circulation 89 1994 1665 1680
77. G. Lee, S. Kumar, and A. Teh et al. Epicardial wave mapping in human long-lasting persistent atrial fibrillation: transient rotational circuits, complex wavefronts, and disorganized activity Eur Heart J 2013 Aug 8 [E-pub ahead of print]
78. T. Baykaner, P. Clopton, A.A. Schricker, G. Lalani, D.E. Krummen, and S.M. Narayan Targeted ablation at stable atrial fibrillation sources improves success over conventional ablation in high risk patients: a substudy of the CONFIRM trial Can J Cardiol 29 2013 1218 1226
79. A.N. Ganesan, P. Kuklik, and D.H. Lau et al. Bipolar electrogram Shannon entropy at sites of rotational activation: implications for ablation of atrial fibrillation Circ Arrhythm Electrophysiol 6 2013 48 57
80. Y.J. Lin, M.T. Lo, and C. Lin et al. Prevalence, characteristics, mapping, and catheter ablation of potential rotors in nonparoxysmal atrial fibrillation Circ Arrhythm Electrophysiol 6 2013 851 858
81. P.S. Cuculich, Y. Wang, and B.D. Lindsay et al. Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns Circulation 122 2010 1364 1372
82. M.A. Allessie, N.M. de Groot, and R.P. Houben et al. The electropathological substrate of longstanding persistent atrial fibrillation in patients with structural heart disease: longitudinal dissociation Circ Arrhythm Electrophysiol 122 2010 1674 1682
83. A.Y. Tan, and P. Zimetbaum Atrial fibrillation and atrial fibrosis J Cardiovasc Pharmacol 57 2011 625 629
84. L. Yue, J. Xie, and S. Nattel Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation Cardiovasc Res 89 2011 744 753
85. A.M. De Jong, A.H. Maass, S.U. Oberdorf-Maass, D.J. Van Veldhuisen, W.H. Van Gilst, and I.C. Van Gelder Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation Cardiovasc Res 89 2011 754 765
86. A.M. De Jong, I.C. Van Gelder, I. Vreeswijk-Baudoin, M.V. Cannon, W.H. Van Gilst, and A.H. Maass Atrial remodeling is directly related to end-diastolic left ventricular pressure in a mouse model of ventricular pressure overload PLoS One 8 2013 e72651
87. A.M. De Jong, A.H. Maass, S.U. Oberdorf-Maass, R.A. De Boer, W.H. Van Gilst, and I.C. Van Gelder Cyclical stretch induces structural changes in atrial myocytes J Cell Mol Med 17 2013 743 753
88. U. Schotten, S. Verheule, P. Kirchhof, and A. Goette Pathophysiological mechanisms of atrial fibrillation: a translational appraisal Physiol Rev 91 2011 265 325
89. B. Burstein, P. Comtois, and G. Michael et al. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure Circ Research 105 2009 1213 1222
90. S. Verheule, E. Tuyls, and A. Gharaviri et al. Loss of continuity in the thin epicardial layer because of endomysial fibrosis increases the complexity of atrial fibrillatory conduction Circ Arrhythm Electrophysiol 6 2013 202 211
91. D. Li, S. Fareh, T.K. Leung, and S. Nattel Promotion of atrial fibrillation by heart failure in dogs: atrial remodelling of a different sort Circulation 100 1999 87 95
92. M.D. Smit, A.H. Maass, A.M. De Jong, A.C. Muller Kobold, D.J. Van Veldhuisen, and I.C. Van Gelder Role of inflammation in early atrial fibrillation recurrence Europace 14 2012 810 817
93. A. Frustaci, C. Chimenti, F. Bellocci, E. Morgante, M.A. Russo, and A. Maseri Histological substrate of atrial biopsies in patients with lone atrial fibrillation Circulation 96 1997 1180 1184
94. M.D. Engelmann, and J.H. Svendsen Inflammation in the genesis and perpetuation of atrial fibrillation Eur Heart J 26 2005 2083 2092
95. M.J. Mihm, F. Yu, and C.A. Carnes et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation Circulation 104 2001 174 180
96. L. Polontchouk, J.A. Haefliger, and B. Ebelt et al. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria J Am Coll Cardiol 38 2001 883 891
97. T. Kato, Y.K. Iwasaki, and S. Nattel Connexins and atrial fibrillation: filling in the gaps Circulation 125 2012 203 206
98. M. Rienstra, I.C. Van Gelder, V.E. Hagens, N.J. Veeger, D.J. van Veldhuisen, and H.J. Crijns Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study Eur Heart J 27 2006 357 364
99. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
100. T. Wang, M. Larson, and D. Levy et al. Inter-relationship between AF and CHF in the Framingham Heart Study Circulation 107 2003 2920 2925
101. R.B. Schnabel, L.M. Sullivan, and D. Levy et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study Lancet 373 2009 739 745
102. G. Ntaios, G.Y. Lip, and K. Makaritsis et al. CHADS2, CHA2DS2-VASc, and long-term stroke outcome in patients without atrial fibrillation Neurology 80 2013 1009 1017
103. A.C. Larstorp, I. Ariansen, and K. Gjesdal et al. Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study Hypertension 60 2012 347 353
104. F.G. Cosio, E. Aliot, and G.L. Botto et al. Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode Europace 10 2008 21 27